ArticleInfection and drug resistance2025
The Impact of Yogurt, Legumes, and Coffee on Health Outcomes in HIV: You are What You Eat?
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: HIV-induced immunodeficiency and comorbidities highlight the importance of nutritional support. While the World Health Organization (WHO) advocates for dietary interventions in people living with HIV (PLWH), robust clinical evidence remains limited. Methods: This study continuously enrolled 280 newly diagnosed PLWH (≥16 years) without opportunistic infections or malignancies. Participants were stratified into high- and low-consumption groups based on dietary intake: yogurt (≥300 mL/week vs <300 mL/week), legumes (≥180 g/week vs <180 g/week), and black coffee (≥3 cups/week vs <3 cups/week), excluding sugary and milk-based coffee. Clinical assessments included laboratory tests, liver fibrosis and steatosis evaluation (FibroScan, AST-to-platelet ratio index [APRI], and controlled attenuation parameter [CAP]), and physical and mental health assessments using the 36-Item Short Form Health Survey (SF-36), the Self-Rating Anxiety Scale (SAS), and the Self-Rating Depression Scale (SDS). Results: At baseline, high-yogurt consumption group had higher CD4+ (P=0.027) and higher CD8+ T-cell counts (P=0.043), lower alcohol use (P=0.001), and higher alanine aminotransferase (ALT) levels (P<0.001). Post antiretroviral therapy (ART), the T-cell count differences disappeared, but BMI and weight gain remained higher (both P<0.001). Legume consumption was not significantly associated with serum lipid profiles but was correlated with lower smoking prevalence (P=0.021), higher ALT levels (P=0.007), and higher CD4+ T-cell counts (P=0.011) at baseline. High coffee consumption was associated with lower APRI scores post-ART (P=0.025) but showed no other significant associations with clinical parameters. No significant associations were found between diet and SF-36, SAS, or SDS scores, except reduced social functioning in high legume and coffee groups. Conclusion: High yogurt consumption was associated with high baseline CD4+ and CD8+ T counts but also associated with increased BMI after ART. However, no significant interactions between dietary intake and ART outcomes were observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.